Percutaneous left atrial appendage closure

摘要: Abstract Introduction Atrial fibrillation is a growing epidemic in the western world. Stroke as most dreaded complication effectively prevented by oral anticoagulation. Although effective preventing stroke, anticoagulants come at price of bleeding complications. Concerns about lead to high rate drug discontinuation and reason many patients are not put on all. Percutaneous left atrial appendage (LAA) closure an excellent option for who cannot or do want be anticoagulants, since origin more than 90% clots arising from atrium. Methods Using femoral venous access, plug placed appendage, thereby excluding this embryologic remnant circulation. The procedure can performed outpatient basis. We report our own experience 100 using Amplatzer cardiac plug. Results One hundred (72 ± 10 years) underwent LAA only local anesthesia without transesophageal guidance. Imaging sizing was contrast injections through 13 French TorqVue delivery sheath, followed device implantation. Clopidogrel prescribed 1 month acetylsalicylic acid 3–6 months. successful 98% often conjunction with other interventional procedures. Periprocedural 6% (2% pericardial effusion, 2% embolization, transient neurologic symptoms) no long-term sequelae. Conclusion attractive alternative anticoagulation suffering fibrillation.